热线电话: 021-34661275
产品分类/PRODUCT CLASSIFICATION

上海细胞库

人源细胞系| 稳转细胞系| 基因敲除株| 基因点突变细胞株| 基因过表达细胞株| 重组细胞系| 猪的细胞系| 马细胞系| 兔的细胞系| 犬的细胞系| 山羊的细胞系| 鱼的细胞系| 猴的细胞系| 仓鼠的细胞系| 狗的细胞系| 牛的细胞| 大鼠细胞系| 小鼠细胞系| 其他细胞系|

原代细胞

原代细胞| 永生化细胞|

细胞培养

血清| 无血清冻存| 细胞培养试剂盒| 普通培养基| 完全培养基| 细胞污染预防| 细胞污染清除| 细胞培养辅助试剂|

细胞服务

STR鉴定服务| ATCC代购服务|

酶联试剂盒

人ELISA试剂盒| 大鼠ELISA试剂盒| 小鼠ELISA试剂盒| 兔ELISA试剂盒| 猪ELISA试剂盒| 鱼ELISA试剂盒| 牛ELISA试剂盒| 犬ELISA试剂盒| 鸭ELISA试剂盒| 豚鼠ELISA试剂盒| 鸡ELISA试剂盒| 绵羊ELISA试剂盒| 山羊ELISA试剂盒| 仓鼠ELISA试剂盒| 植物ELISA试剂盒| 药残留类试剂盒| 其他ELISA试剂盒|

生化试剂盒

生化试剂盒| 微量法检测盒| 分光法检测盒| 胶体金检测盒|

PCR试剂盒

荧光探针PCR试剂盒| 染料荧光PCR试剂盒| 核酸扩增/纯化| 普通PCR检测试剂盒| 质粒菌种感受态|

抗体蛋白

蛋白多肽| 抗体| 免疫组化| 免疫球蛋白|

试剂耗材

标准试液| 科研试剂| 缓 冲 液| 实验耗材| 高效液相色谱对照品|

首页 > 抗体蛋白 > 抗体
APC anti-mouse CD45.2 Antibody
产品名称：
APC anti-mouse CD45.2 Antibody
产品类别：
抗体
产品编号：
109813
产品应用：
109813
[价格]
规格 价格 库存
25µg ￥ 396 1

产品详情

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Mouse
Immunogen
B10.S mouse thymocytes and splenocytes
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD45.2 antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 ?g per 106 cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

The 104 antibody does not react with mouse cells expressing the CD45.1 alloantigen. Additional reported applications (for the relevant formats) include: immunoprecipitation4, in vivo and in vitro blocking of B cell responses1,2, and immunohistochemical staining of acetone-fixed frozen sections3.?

Application References

(PubMed link indicates BioLegend citation)
  1. Yakura H, et al. 1983. J. Exp. Med. 157:1077. (Block)
  2. Yakura H, et al. 1986. J. Immunol. 136:2729. (Block)
  3. Suzuki K, et al. 2000. Immunity 13:691. (IHC)
  4. Shen FW, et al. 1986. Immunogenetics 24:146. (IP)
  5. Baldwin TA and Hogquist KA. 2007. J. Immunol. 179:837.
  6. Pascal V, et al. 2007. J. Immunol. 179:1751.
  7. Burman AC, et al. 2007. Blood 110:1064.
  8. Kincaid EZ, et al. 2007. J. Immunol. 179:3187.
  9. Phan TG, et al. 2007. Nature Immunol. 8:992.
  10. Nakano-Yokomizo T, et al. 2011. J. Exp Med. 208:1661. PubMed
  11. Wen T, et al. 2013. PNAS. 110:6067. PubMed
  12. Kohlmeier JE, et al. 2008. Immunity. 29:101. (FC) PubMed
Product Citations
  1. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  2. Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
  3. Jayachandran R, et al. 2019. Immunity. 50:152. PubMed
  4. Zhang J, et al. 2015. PLoS One. 10:130441. PubMed
  5. Koyama M, et al. 2015. J Exp Med. 212: 1303 - 1321. PubMed
  6. Guo H, Cooper S, Friedman A, et al. 2017. PLoS One. 10.1371/journal.pone.0150809. PubMed
  7. Hirai T, et al. 2020. Immunity. 54(1):84-98.e5. PubMed
  8. Stanzione M, et al. 2022. Sci Adv. 8:eabn1229. PubMed
  9. Krummey SM, et al. 2020. Cell Reports. 30(5):1282-1291.e5.. PubMed
  10. Degn SE et al. 2017. Cell. 170(5):913-926 . PubMed
  11. Gern BH, et al. 2021. Cell Host Microbe. 29(4):594-606.e6. PubMed
  12. Ferrari de Andrade L, et al. 2020. Cancer Immunol Res. 0.867361111. PubMed
  13. Boyd DF, et al. 2020. Nature. 587:466. PubMed
  14. Santamaria-Martínez A, et al. 2009. Exp Cell Res. 315:3004. PubMed
  15. Waide ML, et al. 2020. Cell Rep. 33:108503. PubMed
  16. Brandt S, et al. 2020. J Am Soc Nephrol. 31:2589. PubMed
  17. Liu W, et al. 2021. Cell Mol Immunol. 18:2660. PubMed
  18. Lechner AJ et al. 2017. Cell stem cell. 21(1):120-134 . PubMed
  19. Bowers E, et al. 2018. Nat Med. 24:95. PubMed
  20. Burrack KS et al. 2018. Immunity. 48(4):760-772 . PubMed
  21. Hayatsu N et al. 2017. Immunity. 47(2):268-283 . PubMed
  22. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  23. Fuster JJ, et al. 2020. Cell Rep. 33:108326. PubMed
  24. Lu SX, et al. 2021. Cell. . PubMed
  25. Liu X, et al. 2021. eLife. 0.416666666666667. PubMed
  26. Okuniewska M, et al. 2021. Cell Reports. 36(2):109368. PubMed
  27. Yamamoto K, et al. 2021. Cell Reports. 36(8):109576. PubMed
  28. Osman A, et al. 2021. Nat Immunol. 22:1152. PubMed
  29. Sugita J, et al. 2021. Nat Commun. 12:1910. PubMed
  30. Han CY, et al. 2020. Cell Reports. 31(13):107818. PubMed
  31. Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
  32. Marangoni F, et al. 2021. Cell. . PubMed
  33. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  34. Guo Z, et al. 2016. Nat Commun. 7:10307. PubMed
  35. Brocq M, et al. 2014. J Immunol. 192:6120. PubMed
  36. Levine LS, et al. 2021. Immunity. 54(4):829-844.e5. PubMed
  37. Arsiwala T, et al. 2022. Int J Mol Sci. 23:. PubMed
  38. Wu L, et al. 2022. Theranostics. 12:842. PubMed
  39. Zhou L, et al. 2020. Clin Cancer Res. 26:290. PubMed
  40. Kaplan BLF et al. 2018. Current protocols in toxicology. 75:11:00 25. PubMed
  41. Kleppe M et al. 2018. Cancer cell. 33(1):29-43 . PubMed
  42. Jutz S, et al. 2016. J Immunol Methods. 430:10-20. PubMed
  43. Schadt L, et al. 2020. Cell Reports. 29(5):1236-1248.e7.. PubMed
  44. Dufva O, et al. 2020. Cancer Cell. 38(3):380-399.e13. PubMed
  45. Chen X, et al. 2021. Cell Rep. 37:109991. PubMed
  46. Faulhaber LD, et al. 2022. Neurophotonics. 9:031917. PubMed
  47. Bei T, et al. 2021. Molecules. 26:. PubMed
  48. Markey K, et al. 2012. Blood. 119:5918. PubMed
  49. Woodworth JS, et al. 2017. Mucosal Immunol. 0.802083333. PubMed
  50. Cohen SB et al. 2018. Cell host & microbe. 24(3):439-446 . PubMed
  51. Xu X, et al. 2018. Cell. 175:1336. PubMed
  52. Palazon A, et al. 2017. Cancer Cell. . 10.1016/j.ccell.2017.10.003. PubMed
  53. Mansell E, et al. 2020. Cell Stem Cell. . PubMed
  54. Toubal A, et al. 2020. Nat Commun. 3755:11. PubMed
  55. Ringel AE, et al. 2020. Cell. 183(7):1848-1866.e26. PubMed
  56. Kalinski AL, et al. 2020. Elife. 9:00. PubMed
  57. Markey K, et al. 2014. J Immunol. 192:5426. PubMed
  58. Lim JE, et al. 2022. Front Oncol. 12:1045016. PubMed
  59. Schaefer K, et al. 2014. PLoS One. 9:114824. PubMed
  60. Gordon E, et al. 2015. Proc Natl Acad Sci U S A. 112: 13075 - 13080. PubMed
  61. Deerhake ME, et al. 2021. Immunity. 54(3):484-498.e8. PubMed
  62. Qin Q, et al. 2021. Cell Reports. 35(8):109161. PubMed
  63. Chen X, et al. 2020. Am J Pathol. 190:2056. PubMed
  64. Kondo M, et al. 2016. J Immunol. 196: 563 - 572. PubMed
  65. Guo H, et al. 2014. J Leukoc Biol. 96:419. PubMed
  66. Kimishima Y, et al. 2021. Nat Commun. 12:6177. PubMed
  67. Goldstein JM et al. 2019. Cell reports. 27(4):1254-1264 . PubMed
  68. Garaycoechea JI, et al. 2018. Nature. 553:171. PubMed
  69. Melo-Silva CR, et al. 2021. PLOS Pathogens. 17(5):e1009593. PubMed
  70. Borges da Silva H, et al. 2020. Immunity. 53(1):158-171.e6. PubMed
  71. Berghoff SA, et al. 2021. Nat Neurosci. 24:47. PubMed
  72. Takizawa H, et al. 2011. J Exp Med. 208:273. PubMed
  73. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  74. Firl DJ et al. 2018. eLife. 7 pii: e33051. PubMed
  75. Mandal RK, et al. 2021. Cell Reports. 35(6):109094. PubMed
  76. Zhang C, et al. 2021. J Immunother Cancer. 9:. PubMed
  77. Agrawal M, et al. 2022. Blood. 140:1094. PubMed
  78. Maroni G, et al. 2019. Int J Mol Sci. 20. PubMed
  79. Kobia FM, et al. 2020. PLoS Biol. 18:e3000850. PubMed
  80. Winkler ES, et al. 2020. Cell. 182(4):901-918.e18. PubMed
  81. Düking T, et al. 2022. Sci Adv. 8:eabo7639. PubMed
  82. Koide S, et al. 2022. iScience. 25:103603. PubMed
  83. Pfirschke C, et al. 2020. Cell Rep. 32:108164. PubMed
  84. van der Poel CE, et al. 2019. Cell Rep. 29:2745. PubMed
  85. Habtetsion T et al. 2018. Cell metabolism. 28(2):228-242 . PubMed
  86. Nakazawa Y, et al. 2021. Elife. 10:. PubMed
  87. Asada S, et al. 2018. Nat Commun. 9:2733. PubMed
  88. Xu W, et al. 2021. Immunity. 54(3):526-541.e7. PubMed
  89. Mandal RK, et al. 2020. BMC Biol. 83:18. PubMed
  90. Rivet-Noor CR, et al. 2022. Sci Rep. 12:8594. PubMed
  91. Wu B, et al. 2022. Nat Commun. 13:2155. PubMed
  92. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  93. Harding CL, et al. 2020. Front Cell Infect Microbiol. 10:328. PubMed
  94. Wang X, et al. 2022. Elife. 11:. PubMed
  95. Luo H, et al. 2019. Cell Rep. 26:945. PubMed
  96. Lu Y, et al. 2018. Cancer Cell. 33:1048. PubMed
  97. Hirota K et al. 2018. Immunity. 48(6):1220-1232 . PubMed
  98. Guo Y, et al. 2021. Nat Immunol. 22:746. PubMed
  99. Timilshina M, et al. 2020. Cell Reports. 27(10):2948-2961.e7.. PubMed
  100. Radulovic V, et al. 2020. Cell Reports. 27(10):2826-2836.e5.. PubMed
  101. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  102. Patterson DG, et al. 2021. J Immunol. 207:1798. PubMed
  103. Okubo A, et al. 2021. Int J Mol Sci. 23:. PubMed
  104. Aggarwal N, et al. 2021. Cell Rep. 37:110170. PubMed
  105. Chen S, et al. 2018. Nat Commun. 9:5298. PubMed
RRID
AB_389210 (BioLegend Cat. No. 109813) AB_389211 (BioLegend Cat. No. 109814)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

All hematopoietic cells except mature erythrocytes and platelets of the CD45.2 strain of mice

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
CD Molecules
Antigen References

1. Suzuki K, et al. 2000. Immunity 13:691.

Gene ID
19264 View all products for this Gene ID
UniProt
View information about CD45.2 on UniProt.org

联系我们

TEL：021-34661275 　点击拨打热线